Antibodies to AIDS-associated retrovirus (HTLV-III/LAV) in drug addicts from Vizcaya, northern Spain. 1986

F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre

Serum samples from 313 asymptomatic intravenous (IV) drug users from Bilbao (Vizcaya, Vasque Country, Spain) were tested for antibodies to HTLV-III/LAV virus, the probable etiologic agent of the acquired immune deficiency syndrome (AIDS). Viral antibodies were assayed by ELISA test. 41.9% of the sera gave positive reactions. No seropositivity was detected among 22 normal blood donors, 58 chronic alcoholics, or 20 members of the Drug Control Center personnel. Virus specific reactions were confirmed by indirect immunofluorescence using an HTLV-III/LAV producer cell line, and by Western blotting. 55% of the ELISA-positive sera were also positive in Western blot assay. No differences in seropositivity by age or sex were observed but it increased with the period of parenteral drug use. Presence of antibody statistically correlated with the frequency of syringe sharing, confirming the transmission of viral infection by blood products. Altered T4/T8 ratios and lower number of T4 positive lymphocytes were detected among HTLV-III/LAV positive drug addicts.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D013030 Spain Country located between France on the northeast and Portugal on the west and bordered by the Atlantic Ocean and the Mediterranean Sea. The capital is Madrid. Balearic Islands,Canary Islands
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre
August 1985, Schweizerische medizinische Wochenschrift,
F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre
July 1985, Lancet (London, England),
F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre
January 1987, Microbiologica,
F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre
August 1986, Journal of medical virology,
F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre
September 1986, Revista clinica espanola,
F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre
April 1986, Deutsche medizinische Wochenschrift (1946),
F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre
November 1985, Lakartidningen,
F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre
January 1986, Medicina clinica,
F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre
July 1986, Quintessenz Journal,
F Merino, and B Esparza, and J Aizpiri, and J Fernandez, and L de Masdelval, and A Arrieta, and M Velazquez, and D J Volsky, and E San Cristobal, and A de Izaguirre
January 1986, Pennsylvania medicine,
Copied contents to your clipboard!